Literature DB >> 24813402

Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.

C Beaulieu1, L-L Dionne, A-S Julien, Y Longtin.   

Abstract

Clinical features of Clostridium difficile infections (CDI) detected by PCR, but not by conventional methods, are poorly understood. We compared the clinical features of CDI cases detected by PCR only and cases detected by both PCR and a three-step algorithm. We performed a retrospective cohort study of patients fulfilling a standardized definition over a 13-month period. Stool specimens were tested in parallel by PCR and an algorithm based on enzyme immunoassay and cytotoxicity assay (EIA/CCA). Clinical features of CDI cases detected by PCR only and cases detected by PCR and EIA/CCA were compared by univariate logistic regression. In all, 97 patients (31 PCR+ and 66 PCR+EIA/CCA+) met the inclusion criteria. Compared with cases detected by both PCR and EIA/CCA, CDI cases detected by PCR only were younger (65.4 versus 76.3 years; p 0.001), had a lower absolute neutrophil count (mean, 9.4 × 10(9) /L versus 12.5 × 10(9) /L; p 0.04), were less likely to receive oral vancomycin (2/31 versus 25/66; p 0.005) or combination therapy (0/31 versus 16/66; p 0.04), and had fewer complications (6/31 versus 29/66; p 0.02), despite presenting a higher number of bowel movements on the day of diagnosis (median, 6.0 versus 3.0; p 0.02). They had also a lower C. difficile faecal bacterial load (mean, 5.04 versus 6.89 log10 CFU/g; p <0.001). The CDI cases detected by PCR only and cases detected by both PCR and EIA/CCA have different clinical features, but whether these two populations can be managed differently remains to be determined.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Clinical features; Clostridium difficile; PCR; laboratory diagnosis; patient outcome

Mesh:

Year:  2014        PMID: 24813402     DOI: 10.1111/1469-0691.12676

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  22 in total

Review 1.  Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.

Authors:  Nira R Pollock
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  American society of Nephrology Quiz and Questionnaire 2014: transplantation.

Authors:  Michelle A Josephson; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-10       Impact factor: 8.237

3.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

4.  Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.

Authors:  M J T Crobach; N Duszenko; E M Terveer; C M Verduin; E J Kuijper
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

5.  Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer.

Authors:  Mini Kamboj; Jennifer Brite; Tracy McMillen; Elizabeth Robilotti; Alejandro Herrera; Kent Sepkowitz; N Esther Babady
Journal:  J Infect       Date:  2017-12-08       Impact factor: 6.072

6.  Usefulness of Adjunctive Fecal Calprotectin and Serum Procalcitonin in Individuals Positive for Clostridium difficile Toxin Gene by PCR Assay.

Authors:  Kristin Y Popiel; Romina Gheorghe; Jennifer Eastmond; Mark A Miller
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

7.  Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.

Authors:  Megan D Shah; Joan-Miquel Balada-Llasat; Kelci Coe; Erica Reed; Johanna Sandlund; Preeti Pancholi
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

8.  Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.

Authors:  Alice Y Guh; Kelly M Hatfield; Lisa G Winston; Brittany Martin; Helen Johnston; Geoffrey Brousseau; Monica M Farley; Lucy Wilson; Rebecca Perlmutter; Erin C Phipps; Ghinwa K Dumyati; Deborah Nelson; Trupti Hatwar; Marion A Kainer; Ashley L Paulick; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

9.  Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.

Authors:  Matthew M Hitchcock; Marisa Holubar; Catherine A Hogan; Lucy S Tompkins; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

10.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.